Levobupivacaina Bioindustria L.I.M.

Levobupivacaine, the active ingredient in Levobupivacaina Bioindustria L.I.M., is a local anesthetic (amide type) presented as a sterile solution for epidural, infiltration, intrathecal and other regional anesthesia use. It provides surgical anesthesia, postoperative analgesia and labor analgesia in adult patients undergoing operative or obstetric procedures.

GNH USA supplies Levobupivacaina Bioindustria L.I.M. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levobupivacaine is a long‑acting amide local anesthetic used in regional anesthesia and pain management.

Surgical anesthesia: provides dense intra‑operative analgesia for various surgical procedures. Post‑operative analgesia: extends pain relief after surgery, reducing opioid requirements. Labor analgesia: facilitates effective pain control during childbirth while preserving maternal motor function.

Levobupivacaine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Hypotension: transient drop in blood pressure. - Bradycardia: slowed heart rate. - Dizziness or light‑headedness. - Nausea or vomiting. - Metallic taste in the mouth. - Injection site pain or irritation.

Serious or Rare Side Effects: - Cardiac arrhythmia: abnormal heart rhythms. - Seizures: central nervous system excitation. - Prolonged motor block: extended loss of muscle function. - Allergic reaction: rash, itching, or anaphylaxis. - Methemoglobinemia: reduced oxygen‑carrying capacity of blood. - Central nervous system toxicity: confusion, visual disturbances, or coma.

When using Levobupivacaine, clinicians should observe several safety measures. - Cardiovascular monitoring: continuously assess heart rate and blood pressure during and after administration. - Neurological assessment: watch for signs of CNS toxicity such as tinnitus, metallic taste, or seizures. - Dose adjustment in elderly: consider reduced dosage due to decreased metabolic clearance. - Avoid intravascular injection: aspirate before injection to prevent systemic toxicity. - Use with caution in hepatic impairment: monitor plasma levels and adjust dosing as needed. - Store at ambient temperature: keep in original container, protect from light and moisture.

Levobupivacaine can interact with other medications, requiring careful management.

Major Interactions (Avoid): - Potassium channel blockers: may increase cardiotoxicity risk. - Concurrent use of other local anesthetics: additive CNS and cardiac toxicity. - Class I antiarrhythmics (e.g., quinidine): enhance cardiac effects.

Moderate Interactions (Monitor Closely): - Beta‑adrenergic antagonists: may mask tachycardia signs of toxicity. - General anesthetics: may potentiate central nervous system depression. - Diuretics: may alter plasma concentration and affect clearance.